Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready?

Clinical pharmacology and therapeutics - 1 Apr 2008

Shields A E, Lerman C

Abstract excerpt

Emerging pharmacogenomics research on addiction to nicotine, alcohol, cocaine, and opiates may soon lead to improved clinical outcomes by tailoring the type, dose and duration of treatment to individual patients' genotypes. To realize the potential of pharmacogenomics in reducing the burden of addiction, several challenges related to clinical integration of novel treatment strategies will need to be addressed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genetic Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Health Knowledge, Attitudes, Practice

Share to Pharmacogenetics

Share to Pharmacogenetics and Drug Metabolism

Share to Primary Health Care

Share to Substance-Related Disorders

Source

Identifiers

PMID: 18323859
DOI: 10.1038/clpt.2008.4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready?PMID 18323859Read ↗

Breaking barriers in the genomics and pharmacogenetics of drug addiction.Semantic proximity Read ↗

Anticipating clinical integration of genetically tailored tobacco dependence treatment: perspectives of primary care physicians.Semantic proximity Read ↗

Smoking cessation treatment: pharmacogenetic assessment.Semantic proximity Read ↗

Pharmacogenetics of addiction therapy.Semantic proximity Read ↗

Pharmacogenetics and nicotine addiction treatment.Semantic proximity Read ↗

Nicotine addiction through a neurogenomic prism: Ethics, public health, and smokingSemantic proximity Read ↗

Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility.Semantic proximity Read ↗

Neuroscience and Genetic: Can They Be a Faustian Bargain for Addictive Behaviours Research and Treatment?Semantic proximity Read ↗

Identification of shared Gene/Drug and Gene/Disease genetic associations in a mental health/substance use disorder patient population across an addiction treatment network using Pharmacogenomic testingSemantic proximity Read ↗

Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds.Semantic proximity Read ↗

Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics.Semantic proximity Read ↗

Integrating genetic studies of nicotine addiction into public health practice: stakeholder views on challenges, barriers and opportunities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.